Summary
Stateside move for Acambis research
SMALLPOX vaccine maker Acambis, one of the few profitable UK biotechs, is closing its Cambridge research unit in favour of one in Massachusetts following a company review. Forty jobs will go, and less promising research projects discontinued. The shares rose 15p to 320p.See the full content of this document
Extract
News in Brief
Maiden warning POSTER firm Maiden warned 2003 profits will be lower than expected after improved fo...
See the full content of this document
Sponsored links
